CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...

Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...

CART, a next-gen CAR-T therapy for improved targeting and functionality to address this. “ALA-CART improves the ability of ...

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the ...

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...

A new study reveals that aspirin can reduce cancer metastasis by stimulating the immune system. Researchers found that ...

Identification of pathway provides mechanistic insights into the anti-metastatic effects of aspirin, as a potential basis for ...

Huntsman Cancer Institute's Discovery Innovations showcase the latest advances in cancer treatment, research, and prevention.

The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...

If a cancer returns after it has been in remission, it is defined as a recurrence or relapse of that cancer. Tumors in remission may: Stay in remission indefinitely. Recur and go back into remission ...